Atrys Health, S.A. (BME:ATRY)

Market Cap	207.14M
Revenue (ttm)	226.24M
Net Income (ttm)	-24.59M
Shares Out	75.87M
EPS (ttm)	-0.32
PE Ratio	n/a
Forward PE	30.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	107,009
Average Volume	99,992
Open	2.770
Previous Close	2.820
Day's Range	2.730 - 2.840
52-Week Range	2.480 - 3.670
Beta	0.60
RSI	45.86
Earnings Date	Nov 14, 2025

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,045
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ATRY

Financial Performance

In 2024, Atrys Health's revenue was 218.10 million, an increase of 5.82% compared to the previous year's 206.10 million. Losses were -31.77 million, -30.30% less than in 2023.